Evidence map›Paper›PMID 34454515›Full record

ArticleJournal of translational medicine2021

Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms.

Aurore Nkiliza, Megan Parks, Adam Cseresznye, Sarah Oberlin, James E Evans, Teresa Darcey, Kristina Aenlle, Daniel Niedospial, Michael Mullan, Fiona Crawford and 2 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 30 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 4 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05273372 nacompletednot on this mapstarted 2022, after this paper: background citation

A Randomized Double Blind Placebo Controlled Trial to Determine the Effects of Oxaloacetate on Improving Fatigue in ME/CFS

TypeinterventionalSponsorTerra Biological LLCRan2022 to 2024Enrolled82ConditionsMyalgic Encephalomyelitis, Chronic Fatigue Syndrome, FatigueArmsPlacebo, Medical Food - Anhydrous Enol-Oxaloacetate
NCT05664711 phase1completednot on this mapstarted 2023, after this paper: background citation

Effect of Stellate Ganglion Block on ME/CFS Symptoms and Metabolites

TypeinterventionalSponsorNeuroversion, Inc.Ran2023 to 2024Enrolled10ConditionsEncephalomyelitis, Myalgic, Chronic Fatigue Syndrome, Chronic Fatigue Disorder, Chronic Fatigue and Immune Dysfunction SyndromeArmsBupivacaine Injection
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 4 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Recent research in myalgic encephalomyelitis/chronic fatigue syndrome: an evidence map.Health technology assessment (Winchester, England) · 2025
    Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Aurore NkilizaRoskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, USA. ankiliza@roskampinstitute.org.ORCID 0000-0002-6102-1142
Megan ParksRoskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, USA.
Adam CseresznyeRoskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, USA.
Sarah OberlinRoskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, USA.
James E EvansRoskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, USA.
Teresa DarceyRoskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, USA.
Kristina AenlleInstitute for NeuroImmune Medicine, VAMC, GRECC, Nova Southeastern University, Miami, USA.
Daniel NiedospialRoskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, USA.
Michael MullanRoskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, USA.
Fiona CrawfordRoskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, USA.
Nancy KlimasInstitute for NeuroImmune Medicine, VAMC, GRECC, Nova Southeastern University, Miami, USA.
Laila AbdullahRoskamp Institute, 2040 Whitfield Ave, Sarasota, FL, 34243, USA.
James A. Haley Veterans' Hospital · USNova Southeastern University · US

Funding

Gender Differences in Myalgic Encephalomyelitis/Chronic Fatigue SyndromeR01NS090200 · NINDS · NOVA SOUTHEASTERN UNIVERSITY · PI FLETCHER, MARY A · 2014 to 2017
$2.0M
Application of lipidomics to identify biomarkers of immune and mitochondrial disturbances in Chronic Fatigue Syndrome.R21AI142717 · NIAID · ROSKAMP INSTITUTE, INC. · PI ABDULLAH, LAILA, CRAWFORD, FIONA C. · 2019 to 2020
$410k
NIAID NIH HHS R21 AI142717NIH HHS 1R21NS106212NIH HHS R01NS090200
6 · The paper itself

Abstract

backgroundMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex illness which disproportionally affects females. This illness is associated with immune and metabolic perturbations that may be influenced by lipid metabolism. We therefore hypothesized that plasma lipids from ME/CFS patients will provide a unique biomarker signature of disturbances in immune, inflammation and metabolic processes associated with ME/CFS.

methodsLipidomic analyses were performed on plasma from a cohort of 50 ME/CFS patients and 50 controls (50% males and similar age and ethnicity per group). Analyses were conducted with nano-flow liquid chromatography (nLC) and high-performance liquid chromatography (HPLC) systems coupled with a high mass accuracy ORBITRAP mass spectrometer, allowing detection of plasma lipid concentration ranges over three orders of magnitude. We examined plasma phospholipids (PL), neutral lipids (NL) and bioactive lipids in ME/CFS patients and controls and examined the influence of sex on the relationship between lipids and ME/CFS diagnosis.

resultsAmong females, levels of total phosphatidylethanolamine (PE), omega-6 arachidonic acid-containing PE, and total hexosylceramides (HexCer) were significantly decreased in ME/CFS compared to controls. In males, levels of total HexCer, monounsaturated PE, phosphatidylinositol (PI), and saturated triglycerides (TG) were increased in ME/CFS patients compared to controls. Additionally, omega-6 linoleic acid-derived oxylipins were significantly increased in male ME/CFS patients versus male controls. Principal component analysis (PCA) identified three major components containing mostly PC and a few PE, PI and SM species-all of which were negatively associated with headache and fatigue severity, irrespective of sex. Correlations of oxylipins, ethanolamides and ME/CFS symptom severity showed that lower concentrations of these lipids corresponded with an increase in the severity of headaches, fatigue and cognitive difficulties and that this association was influenced by sex.

conclusionThe observed sex-specific pattern of dysregulated PL, NL, HexCer and oxylipins in ME/CFS patients suggests a possible role of these lipids in promoting immune dysfunction and inflammation which may be among the underlying factors driving the clinical presentation of fatigue, chronic pain, and cognitive difficulties in ill patients. Further evaluation of lipid metabolism pathways is warranted to better understand ME/CFS pathogenesis.

Indexed as

Fatigue Syndrome, ChronicBiomarkersCognitionFemaleHumansInflammationMalePainBiomarkersImmunityInflammationLipidomicMyalgic encephalomyelitis/chronic fatigue syndrome

Identifiers

PMID34454515
PMCPMC8401202
OpenAlexW3197447391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.